EP0484385A1 - Quantification de bacteries au moyen d'un dosage d'hybridation d'acide nucleique - Google Patents

Quantification de bacteries au moyen d'un dosage d'hybridation d'acide nucleique

Info

Publication number
EP0484385A1
EP0484385A1 EP90911234A EP90911234A EP0484385A1 EP 0484385 A1 EP0484385 A1 EP 0484385A1 EP 90911234 A EP90911234 A EP 90911234A EP 90911234 A EP90911234 A EP 90911234A EP 0484385 A1 EP0484385 A1 EP 0484385A1
Authority
EP
European Patent Office
Prior art keywords
probe
bacteria
nucleic acid
sample
hybridization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP90911234A
Other languages
German (de)
English (en)
Other versions
EP0484385A4 (en
Inventor
Trevor H. Adams
Dennis E. Schwartz
Nicolaas M. J. Vermeulen
Roy H. Kanemoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
MicroProbe Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co, MicroProbe Corp filed Critical Becton Dickinson and Co
Publication of EP0484385A1 publication Critical patent/EP0484385A1/fr
Publication of EP0484385A4 publication Critical patent/EP0484385A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms

Definitions

  • This invention provides for a method of quantifying bacteria using a bacterial specific nucleic acid probe which is complementary to a unique, open and highly conserved region of the 16S ribosomal RNA (rRNA) of bacteria.
  • rRNA 16S ribosomal RNA
  • Oligonucleotides reflecting the UP9A region were described by Woese, C.R., et al., (1975), Conservation of primary structure in 16S ribosomal RNA, Nature 254:83-85 (see Table 1, oligos 47,
  • Periodontal Res. 22:335-341 Microbial counts were used to determine the effectiveness of tetracycline for prevention of periodontal disease by the- Forsyth Center and reported in J. of Dental Res.
  • This invention provides for a method of measuring the quantity of bacteria in a biological sample which comprises lysing the bacteria in the sample and contacting the lysate under hybridization conditions with an oligonucleotide probe having a sequence of 5'CTGCTGCCTCCCGTAGGAGT3* .
  • an oligonucleotide probe having a sequence of 5'CTGCTGCCTCCCGTAGGAGT3* is a sequence of 5'CTGCTGCCTCCCGTAGGAGT3* .
  • 5'CTGCTGCCTCCCGTAGGAGT3• is meant to include functional equivalents of this sequence. Such equivalents are described in greater detail below but embrace nucleic acid analogs and minor mismatched oligonucleotides, such that the probes will bind specifically to the target region on the 16S rRNA to which the claimed sequence is complementary.
  • lysate refers to solutions containing bacterial nucleic acid.
  • a lysate would include crude mixtures of disrupted bacteria, semi-purified solutions and purified solutions of bacterial nucleic acid.
  • the claimed probe may either be a capture probe or signal probe.
  • Capture probes are unlabelled probes which bind to target nucleotides and subsequently capture the target to a solid support.
  • Signal probes are adapted to be used for the generation of a signal, for example a probe with a avidin moiety. Samples can be obtained from any biological source including a human being and particularly from blood, mouth region or anogenital region.
  • the method can be further enhanced by the addition of at least one additional nucleic acid probe which is species specific, genus-specific or strain-specific. These additional probes can provide qualitative information in addition to quantification of bacteria.
  • This invention also provides for diagnostic kits utilizing the above technology.
  • This invention relates to the use of a unique sequence of nucleic acid, designated UP9A, which provides universal binding to the 16S rRNA (see Table 1) .
  • This sequence is particularly unique to bacterial rRNA and does not significantly hybridize to human nucleic acid.
  • this sequence is located in a region of the ribosome where it is available for hybridization with only minimal disturbance of the secondary structure of the rRNA.
  • Target sequences having this characteristic are termed "open" regions because of their relative availability for hybridization.
  • Quantification of bacteria is dependent upon the ability of the assay to react in a predictable manner to increasing amounts of rRNA.
  • the UP9A probe reacts in predictable manner, typically by offering a direct and linear response to increasing amounts of bacterial rRNA. By preparation of and by comparison to appropriate standards, one can readily quantify the total bacterial count in a sample using the disclosed invention.
  • Bacterial counts are of particular use in diagnosing disease states where high bacterial counts are indicative of the particular disease state. For example bacterial counts are useful in diagnosing periodontal disease, stomach ulcers, bacteremia, and urinary tract infections. In addition, rapid bacterial quantification is often desirable during food preparation and fermentation processes.
  • the degree of complementarity (homology) required for detectable binding of UP9A probes with the rRNA of bacteria will vary in accordance with the stringency of the hybridization medium and/or wash medium.
  • the degree of complementarity will optimally be 100 percent; however, it should be understood that minor variations between the rRNA and UP9A may be compensated for by reducing the stringency of the hybridization and/or wash medium as described below.
  • functional probes having minor base differences from their rRNA targets are possible. Therefore, under hybridization conditions of reduced stringency, it may be possible to slightly modify the UP9A probe while maintaining an acceptable degree of specificity to quantify total bacteria present.
  • the UP9A oligonucleotide may be a compound of RNA or DNA.
  • analogs of nucleosides may be substituted for naturally occurring nucleosides. The advantage of analogs would include greater stability, resistance to nuclease activity and ease of signal attachment.
  • the term UP9A is intended to embrace all functionally equivalent species. Equivalent UP9A probes may also consist of the given sequence, concatemers of the sequence, or probes flanked by about 10 or less bases of any degree of complementarity to the native sequences flanking the UP9A complementary region of bacterial rRNA.
  • UP9A probe may be chemically synthesized using commercially available methods and equipment.
  • the solid phase phosphoramidite method can be used to produce short probes of between 15 and 50 bases.
  • UP9A probes To obtain large quantities of UP9A probes, one can also clone the desired sequence using traditional cloning methods, such as described in Maniatis, T. , et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York, 1982, or one can produce the probes by chemical synthesis using commercially available DNA synthesizers.
  • An example of cloning would involve insertion of the cDNA for the ribosomal RNA into a replication vector, such as pBR322, M13, or into a vector containing the SP6 promotor (e.g., generation of single- stranded RNA using SP6 RNA polymerase) , and transformation of a bacterial host.
  • the DNA probes can be purified from the host cell by lysis and nucleic acid extraction, treatment with selected restriction enzymes, and further isolation by gel electrophoresis.
  • the use of polymerase chain reaction technology can also be used to obtain large quantities of the UP9A probe.
  • the UP9A probe can be used as a capture probe in a sandwich-type assay where the bacterial rRNA is the target nucleic acid and a second or other signal probes facilitates detection.
  • Table 1 provides UP7B and UP3A which are useful as additional universal probes for signal detection.
  • UP9A probes can also serve as signal probes. Signal probes may be labeled by any one of several methods typically used to detect the presence of hybrid polynucleotides.
  • the most common method of detection is the use of autoradiography with 3 ⁇ 125 ⁇ 35 s ⁇ 14 ⁇ Qr 32 p labeled prob es or the like.
  • the choice of radioactive isotope depends on research preferences due to ease of synthesis, stability and half lives of the selected isotopes.
  • Other labels include ligands which bind to antibodies labeled with fluorophores, chemiluminescent agents, and enzymes.
  • probes can be conjugated directly with labels such as fluorophores, chemiluminescent agents or enzymes.
  • the choice of label depends on sensitivity required, ease of conjugation with the probe, stability requirements, and available instrumentation.
  • Radioactive probes are typically made using commercially available nucleotides containing the desired radioactive isotope.
  • the radioactive nucleotides can be incorporated into probes, for example, by using DNA synthesizers, by nick translation with DNA polymerase I, by tailing radioactive DNA bases to the 3 ⁇ end of probes with terminal deoxynucleotidyl transferase, by treating single- stranded M13 plasmids having specific inserts with the Klenow fragment of DNA polymerase in the presence of radioactive deoxynucleotides (dNTP) , by transcribing from RNA templates using reverse transcriptase in the presence of radioactive deoxynucleotides (dNTP) , or by transcribing RNA from vectors containing specific RNA viral promoters (e.g., SP6 promoter) using the corresponding RNA polymerase (e.g., SP6 RNA
  • the probes can be labeled using radioactive nucleotides in which the isotope resides as a part of the nucleotide molecule, or in which the radioactive component is attached to the nucleotide via a terminal hydroxyl group that has been esterified to a radioactive component such as inorganic acids, e.g. , 32P phosphate or 14C organic acids, or esterified to provide a linking group to the label.
  • Base analogs having nucleophilic linking groups, such as primary amino groups, can also be linked to a label.
  • Non-radioactive probes are often labeled by indirect means.
  • a ligand molecule is covalently bound to the probe.
  • the ligand then binds to an anti-ligand molecule which is either inherently detectable or covalently bound to a detectable signal system, such as an enzyme, a fluorophore, or a chemiluminescent compound.
  • Ligands and anti-ligands may be varied widely. Where a ligand has a natural anti-ligand, namely ligands such as biotin, thyroxine, and cortisol, it can be used in conjunction with its labeled, naturally occurring anti-ligands. Alternatively, any haptenic or antigenic compound can be used in combination with an antibody.
  • Probes can also be labeled by direct conjugation with a label.
  • cloned DNA probes have been coupled directly to horseradish peroxidase or alkaline phosphatase, (Renz. M. , and Kurz, K. A Colorimetric Method for DNA Hybridization. Nuc. Acids Res. 12:3435-3444, 1984) and synthetic olignucleotides have been coupled directly with alkaline phosphatase (Jablonski, E., et al., Preparation of Oligodeoxynucleotide-alkaline phosphatase Conjugates and Their Use as Hybridization Probes. Nuc. Acids. Res.
  • Enzymes of interest as labels will primarily be hydrolases, such as phosphatases, esterases and glycosidases, or oxidoreductases, particularly peroxidases.
  • Fluorescent compounds include fluorescein and its derivatives, rhodamine and its derivatives, dansyl, umbelliferone, etc.
  • Chemiluminescers include luciferin, and 2,3- dihydrophthalazinediones, e.g.. luminol.
  • Microbial specimens for use in this invention can be obtained from any source suspected of harbouring bacteria.
  • the sample collection means should be uniform and reproducible such that meaningful comparisons can be made.
  • the samples are generally dispersed in a measured amount of buffer, though dispersal may be optimal if lysis is immediately possible.
  • This dispersal buffer generally provides a biologically compatible solution.
  • a typical dispersal buffer solution would be 150mM NaCl, 20mM Tris-HCl (pH 7.5), lOmM EDTA, 10mM ethylene glycol-bis (0-aminoethyl ether) N N,N'N I - tetraacetic acid (EGTA) or 150mM NaCl, 20mM NaPO (pH 7.5), lOmM EDTA, lOmM EGTA. Samples may be frozen until use.
  • Lysing buffers are known in the art. EP 199,439; Potts, T.V. and Berry, Em. Internat. J. Sys. Bacter. , 33:765-771 (1983); Bonta, Y., et al., J. Dent. Res., 64:793- 798 (1985). Generally, these buffers are between pH 7.0 and 8.0, and contain both chelating agents and surfactants.
  • a lysing solution is a buffered detergent solution having a divalent metal chelator or a buffered chaotrophic salt solution containing a detergent (such as SDS) , a reducing agent and a divalent metal chelator (EDTA) .
  • a detergent such as SDS
  • EDTA divalent metal chelator
  • enzymes such as N-acetyl-muramidase (lysozyme) or proteases (such as Protease ) will facilitate lysis and offer high quality results.
  • the sample may be directly immobilized to a support or further processed to extract nucleic acids prior to immobilization.
  • Released or extracted bacterial nucleic acid (including target nucleic acid) are fixed to a solid support, such as cellulose, nylon, nitrocellulose, diazobenzyloxymethyl cellulose, and the like.
  • the immobilized nucleic acid can then be subjected to hybridization conditions.
  • samples may be collected and dispersed in a lysing solution that also functions as a hybridization solution, such as 3M guanidinium thiocyanate (GuSCN) , 50mM Tris (pH 7.6), lOmM EDTA, 0.1% sodium dodecylsulfate (SDS), and 1% ercaptoethanol (Maniatis, T. et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York, 1982).
  • a hybridization solution such as 3M guanidinium thiocyanate (GuSCN) , 50mM Tris (pH 7.6), lOmM EDTA, 0.1% sodium dodecylsulfate (SDS), and 1% ercaptoethanol (Maniatis, T. et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, New York, 1982).
  • hybridization solutions comprising from about 20 to 60% volume, preferably 30%, of a polar organic solvent.
  • a common hybridization solution employs about 50% v/v formamide, about 0.5 to IM sodium chloride, about 0.05 to 0.1M buffers, such as sodium citrate, Tris-HCl, PIPES or HEPES (pH range about 6-9), about 0.05 to 0.2% detergent, such as sodium dodecylsulfate, or between 0.5-20mM EDTA, 0.01-0.05% ficoll (about 300-500 kilodaltons) , 0.01-0.05% polyvinylpyrrolidone (about 250-500 kdal), and 0.01-0.05% serum albumin.
  • unlabeled carrier nucleic acids from about 0.1 to 5 mg/ml, fragmented nucleic DNA, e.g.. calf thymus or salmon sperm DNA, or yeast RNA, and optionally from about 0.5 to 2% wt./vol. glycine.
  • Other additives may also be included, such as volume exclusion agents which include a variety of polar water-soluble or swellable agents, such as polyethylene glycol, anionic polymers such as polyacrylate or polymethylacrylate, or polystyrene sulfonic acid and anionic saccharidic polymers, such as dextran sulfate.
  • An alternative hybridization solution may be employed comprising about 2 to 4M GuSCN, preferably 3M, about 0.01 to 0.1M Tris (pH range about 6.0 to 8.5), a detergent such as sodium dodecyl sulfate in concentrations of about 0.1 to 5% (w/v) , and about 0.01 to 0.1M EDTA.
  • Other additives may also be included such as carrier DNA or RNA, or protein such as bovine serum albumin or gelatin.
  • Stringency of the hybridization solution can be adjusted by the addition of about 0 to 10% formamide, usually 5%.
  • the particular hybridization technique is not essential to the invention. Hybridization techniques are generally described in Nucleic Acid Hybridization: A Practical Approach, Ed. Hames, B.D.
  • the amount of labeled probe which is present in the hybridization solution may vary widely, depending upon the nature of the label, the amount of the labeled probe which can reasonably bind to the cellular target nucleic acid, and the stringency of the hybridization medium and/or wash medium.
  • the degree of stringency of hybridization can be employed. As the conditions for hybridization become more stringent, there must be a greater degree of complementarity between the probe and the target for duplex formation to occur.
  • the degree of stringency can be controlled by temperature, ionic strength, pH and the presence of a partially denaturing solvent such as formamide.
  • the stringency of hy ⁇ bridization is conveniently varied by changing the polarity of the reactant solution through manipulation of the concentration of formamide within the range of 0% to 50%.
  • Assay test protocols for use in this invention are those of convention in the field of nucleic acid hybridization, and include both single phase, where the target and probe polynucleic acids are both in solution, and mixed phase hybridizations, where either the target or probe polynucleotides are fixed to an immobile support.
  • the assay test protocols are varied and are not to be considered a limitation of this invention.
  • a general review of single phase hybridization can be had from a reading of Nucleic Acid Hybrid ⁇ ization: A Practical Approach, Ed. Hames, B.D. and Higgins, S.J., IRL Press, 1985, and Hybridization of Nucleic Acids Immo ⁇ bilized on Solid Supports, Meinkoth, J. and Wah, G. , Analytical Biochemistry, pp. 238, 267-284, 1984.
  • Mixed phase hybridizations are preferred.
  • Nucleic acids from GuSCN-lysed bacteria can be immobilized directly on to nitrocellulose or Nytran, and hybridized with the appropriate probe.
  • the GuSCN-lysate is diluted with buffer containing formaldehyde, slotted to nitrocellulose and heated at 80°C to denature the nucleic acids.
  • the bacterial cells are to remain in contact with a hybridization solution at a moderate temperature for an extended period of time.
  • the double-stranded duplexes may be separated from single-stranded nucleic acid by S nuclease digestion followed by precipitation of duplex molecules, or by selective binding to hydroxyapatite.
  • the support-immobilized nucleic acid is introduced into a wash solution having analogous concentrations of sodium chloride, buffers, and detergent, as provided in the hybridization solution. The time period for which the support is maintained in the wash solution may vary from several minutes to three hours or more.
  • Either the hybridization or the wash medium can be stringent. Typically, for mixed phase assays, it is the wash solution that most often determines the stringency and facilitates dissociation of mismatched duplexes. After rinsing the support at room temperature with a dilute buffered sodium chloride solution, the support may now be assayed for the presence of duplexes in accordance with the nature of the label.
  • the presence of probe can be detected in a scintillation counter. More conveniently, in mixed phase assays, the substrate can be dried and exposed to X-ray film in any number of conventional autoradiographic protocols.
  • the sample is detected by first irradiating it with light of a particular wavelength. The sample absorbs this light and then emits light of a different wavelength which is picked up by a detector (Physical Biochemistry, Freifelder, D. , W.H. Freeman & Co., pp. 537-542, 1982).
  • the label is a hapten or antigen
  • the sample can be detected by using antibodies. In these systems, a signal is generated by attaching fluorescent or enzyme molecules to the antibodies; in some cases the antibody is labeled with a radioactive probe. (Tijssen, P. , Practice and Theory of Enzyme Immunoassays. Laboratory Techniques in Biochemistry and Molecular Biology, Burdon, R.H.
  • One method of detection is enzymatic detection in conjunction with biotin.
  • fluorescence is an alternative label
  • enzymatic labels in combination with avidin or streptavidin such as biotinylated peroxidase or alkaline phosphatase, are preferred.
  • Enzyme-conjugated avidin or streptavidin can also be used to directly bind the enzyme to the probe (Haase, et al., supra) .
  • Preferred enzymes are peroxidase or alkaline phosphatase.
  • An especially preferred method utilizes enzymes directly conjugated to probes.
  • the preferred enzymes are alkaline phosphatase and peroxidase. Methods for conjugating enzymes to oligonucleotides are known. Nucleic Acid Res., 14:6115-6128 (1986) and Nucl. Acid Res., 15:5275-5287 (1987)..
  • the UP9A assay protocol is a sandwich-type assay.
  • a primary component of a sandwich-type assay is a solid support.
  • the solid support has adsorbed to it or covalently coupled to it immobilized nucleic acid probe that is unlabeled and complementary to one portion of the rRNA sequence.
  • Preferred are those probes that hybridize to regions of the ribosomal RNA with minimal secondary and tertiary interactions, such as those listed in Table 1.
  • the advantage of such probes is that the hybridization can be carried out without the additional step of heat denaturing the sample nucleic acid.
  • the test sample suspected of containing bacteria is then contacted with the solid support in a hybridization medium.
  • a second soluble-labeled probe complementary to a different sequence of the rRNA of the pathogenic bacteria is hybridized to the rRNA that has formed a hybridization duplex with the immobilized nucleic acid probe on the solid support.
  • the UP9A probe may function as either a capture or signal probe.
  • the assay format may be a mixed phase, non-sandwich type assay.
  • the entire assay takes place at room temperature.
  • the bacterial sample is lysed in the lysis/hybridization solution which contains one Nytran capture filter and biotinylated signal oligonucleotides.
  • the hybridization is complete in 40 minutes with vigorous shaking (optional) .
  • the filter is washed free of hybridization solution and allowed to bind with streptavidin-HRP for 5 minutes with vigorous shaking.
  • the filter is again washed, then placed in development solution for 10 minutes with gentle shaking. Color development is stopped by a final wash and the filter evaluated.
  • the proportion of UP9A bound to a matrix of bacterial rRNA will increase predictably and reproducibly with the amount of bacterial rRNA in the matrix.
  • To accurately quantify the amount of rRNA present in a sample one has to prepare standards for comparison. Virtually any label or detection means of use in nucleic acid hybridizations can be standardized and quantified for use with the UP9A probe.
  • the standards are prepared by taking known quantities of bacteria harboring the UP9A complementary sequence and using such bacteria as a control to compare the intensity of the hybridization signal to the unknown samples.
  • the quantity of signal must correlate with the amount of hybridization such that comparison between the standard and unknowns is possible.
  • the intensity of an autoradiogram can be used to compare relative amounts of hybridization.
  • a densitometer is used for comparisons.
  • the use of an enzyme-linked probe in a colorimetric assay format would permit the use of automated systems to measure the quantity of bacteria. This is analogous to an ELISA procedure where a spectrophotometer is used to determine the quantity of antigen present in an unknown sample. Kits
  • kits for clinical laboratories. Such kits would include instruction cards and vials containing the various solutions necessary to conduct a nucleic acid hybridization assay. These solutions would include lysing solutions, hybridization solutions, combination lysing and hybridization solutions, and wash solutions. The kits would also include labelled probes.
  • the UP9A probe could be either unlabelled or labelled depending on the assay format. Standard references for comparison of results would also be necessary to provide an easy estimate of bacterial numbers in a given solution. Depending upon the label used additional components may be needed for the kit, e.g., enzyme labels require substrates.
  • Total bacterial count is sometimes referred to as "bacterial load.”
  • a lysis solution composed of 3 M GuSCN, 2% Sarkosyl, 50 mM Tris, pH 7.6, 25 mM EDTA was used to lyse a mixture of 1 x l ⁇ 8 cells of Aa, Bg, Bi, Ec, Fn and Wr in 100 microliter volumes at 19"C. The lysate was then heated in a 65° water bath for 10 minutes.
  • Biotinylated 24-mer oligonucleotide probes (UP7B and UP3A) complementary to conserved regions of bacterial 16s rRNA (signal probes) were added to a final concentration of 100 nanograms per ml to both the lysate and to the 3 M GuSCN lysing solution that was to be used as the diluent. Seven, ten-fold serial dilutions were then made with the heated lysate and then this solution was incubated with nytran discs which had covalently immobilized 1 microgram of UP9A specific oligonucleotide probe (capture probe) for 1 hour at ambient temperature.
  • the solid supports were then washed with SDS/FW (.01-2.0% sodium dodecyl sulfate and a filter wash (FW) of 0.09 M NaCl, 0.01 M TRIS-HC1 at pH 7.6 and 5 mM EDTA) at ambient temperature and then incubated with 10 ng/ml of Streptavidin/Horseradish peroxidase (SA/HRP) conjugate in SDS/FW for 30 minutes at ambient temperature.
  • SA/HRP Streptavidin/Horseradish peroxidase
  • the solid supports were then washed with SDS/FW, FW, and then the presence of peroxidase was determined by incubating the filter with 3 mM 4-methoxynaphthol in 0.1 M citrate buffer, pH 5.5 for 15 minutes. The results indicated that a level of sensitivity of 1 x 10 6 bacterial cells was achieved using the heated GuSCN lysate.
  • Table 4 illustrates a comparison of the cell numbers determined by micro-culture and by probe analysis. As explained in the experimental section below the number of bacteria can be estimated in the samples by comparing the signal strength of unknowns with that of the standards. It has previously been shown on Nytran slot blots with total nucleic acid extracts of a panel of 72 strains of 14 different bacteria that the signal strengths were comparable when hybridized with 32 P labeled UP9A. Table 4.A Comparison of Bacterial Cell Numbers Determined By Micro-Cultural and Probe Analysis.
  • microbiological cell count represents only live bacteria it is expected that probe cell count will generally be higher, since it detects the presence of total nucleic acid isolated from both viable and non-viable bacteria.
  • Plaque samples were collected by curette and deposited into 2 ml of a buffer (0.115 M NaCl, 0.2 M Tris- HC1, pH 7.5, 0.01 M EDTA, pH 7.5 and 0.01 M EGTA). When done carefully, one can reproducibly remove up to 90% of the bacteria present in an oral tooth pocket using curettes. The remaining amount of each sample (after 1/20th was taken for microbiological culturing was stored at -20°C for several days. Upon thawing, the samples were treated with 1% W/V SDS and 1 mg/ml proteinase K. The total nucleic acid was extracted with two phenol-chloroform extractions and then precipitated with ethanol.
  • the pellet was resuspended in TE (10 mM Tris, 1 mM EDTA), heated for one minute at 95°C in the presence of 10 mM Pipes, pH 7.6, and slotted onto a Nytran membrane filter.
  • the nucleic acid was immobilized onto the Nytran filter by baking for 1 hour at 80 ⁇ c.
  • This filter was probed with kinased 32-P labeled universal primer oligonucleotide (UP9A) in a 30% formamide hybridization solution (30% formamide, 0.6 M NaCl, 90 mM Tris, 10 mM EDTA, 0.5% W/V SDS,- 5X Denhardt's, 100 ⁇ g/ml hydrolyzed yeast- RNA) at 43°C for 16 hours.
  • the filter was washed in 0.09 M NaCl, 9 mM Tris, 0.6 mM EDTA at 50°C then exposed to x-ray film.
  • the resulting autoradiograph was compared to a standard of cultured bacteria, prepared and treated in the same manner (see below) .
  • Example 3 The UP9A probe is a universal probe for Eubacteria plastids
  • Tests were conducted against 78 different strains of bacteria including the following genera: Actinobacillus, Haemophilus, Bacteroides, Eikenella, Fusobacterium, Wolinella, Campylobacter, Escherichia, Peptostreptococcus, Streptococcus, Capnocytophaga, Selenomonas, Actinomyces and Fusobacterium. Nucleic acids from the different bacteria were extracted and slotted onto a Nytran filter. This filter was then probed with a kinased UP9A oligo in a 30% formamide, 0.6M NaCl hybridization solution at 43°C for 16 hours.
  • the filter was then washed in a 0.09 M NaCl/0.1% SDS solution at 50°C before exposure to X-ray film.
  • the degree of hybridization was rated for all species tested, strong (3), medium (2), weak (1), none detected (0).
  • UP9A gave strong hybridization results for all bacterial species tested.
  • UP9A is a universal probe for eubacteria and plastids.
  • the probe hybridizes specifically with nucleic acids (especially rRNA) from these two groups.
  • the probe hybridizes only weakly to archaebacteria and eukaryote nucleic acids.
  • Example 4 Total Bacterial Counts Using Sandwich Assays
  • UP9A as a capture oligonucleotide and terminal transferase polybiotinylated UP3A and UP7B as signal oligonucleotides
  • total bacterial cell numbers were determined first in mixed periodontal (PD) bacterial cell cultures and secondly in plaque samples.
  • About 50 plaque samples were classified by a dental hygienist as severe, moderate and normal according to clinical parameters used in the dental field.
  • the samples were analyzed in a sandwich assay using UP9A as a capture probe. In preliminary results, its was found that there was a positive trend between disease severity and total bacteria present. The total bacteria counts were not done on these samples and we cannot make an absolute conclusion at this time.
  • UP9A is particularly specific for bacteria and exhibits low crossreactivity with nucleic acid of human origin.
  • Four human tissue culture cell types (A549 - lung carcinoma, HeLa and SiHa - both cervical carcinomas, and T2 - lympho a) were lysed in 6M GuSCN. Fresh blood was also lysed in GuSCN. 10 8 , 10 7 , 10 6 and 10 5 bacterial cell equivalents (bee) of human cells and PD bacterial cells (control) , plus 5 and 25 ⁇ l of blood were set up in the 100 ⁇ l volume sandwich assay. It is assumed that human nucleic acid is a 1000 times more complex than bacterial nucleic acid.
  • Example 6 Specific Detection of Bg Bacterium in Pyrrolidone-Based Hybridization Media.
  • a hybridization media composed of 20% N-cyclohexyl- 2-pyrrolidone, and 20% N-Hydroxymethyl-2-pyrrolidone, 50 mM Tris, pH 7.6, 25mM EDTA, and 2% SDS was used to lyse 1 x 10 8 cells of Aa, Bi, Ec, Wr, Fn, or Bg in 100 microliter volumes at 19°C.
  • Biotinylated 24-mer oligonucleotide probes complementary to conserved regions of bacterial 16S rRNA (target probes) were added to a final concentration of 100 nanograms per ml.
  • Example 7 One Step Assay to Detect Specific Nucleic Acid Seguences of Bacterial Pathogens A pre-prepared Pyrrolidone Lysis Solution (PLS) composed of 20% N-cyclohexyl-2-pyrrolidone, 20% N- hydroxymethyl-2-pyrrolidone, 10% N-dodecyl-2-pyrrolidone, 50 mM Tris, pH 7.6, 25 mM EDTA, and 2% SDS and containing 1 to 5 mg of 5 micron beads (silica, (Spherisorb) from Phase Sep, Deeside Ind.
  • PLS Pyrrolidone Lysis Solution
  • Example 8 Assay to Detect Specific Nucleic Acid Sequences of Pathogenic Bacteria in a Proteinase K/SDS/guanidine Thiocyanate Lysis/Hybridization Solution A pre-prepared solution composed of 0.2 mg/ l
  • Proteinase K, 0.2% SDS in anaerobic growth media (brain heart infusion 30g/l, soluble starch lOg/1, gelatin lg/1 in lOmM pipes buffer pH8) , are added to lxlO 8 cells of Aa, Bi, Bg, Ec, Wr, Fn cultured bacteria respectively and left at room temperature for 3 minutes.
  • An equal volume of 6M guanidine thiocyanate lysis solution containing lOOng/ml of biotinylated 24-mer oligonucleotide probes complementary to the conserved regions of the bacterial 16S rRNA is added (UP9A) .
  • guanidinium cell lysis solution (GuCLS)
  • nytran discs which has covalently immobilized 1 microgram of Aa, Bg, Bi, Ec, Wr, Fn specific oligonucleotide probes (capture probe) respectively for 20 minutes at ambient temperature.
  • the solid supports were then washed with SDS/FW at ambient temperature and then incubated with lOng/ml of Streptavidin/Horseradish peroxidase (SA/HRP) conjugate in SDS/FW for 5 to 10 minutes at ambient temperature.
  • SA/HRP Streptavidin/Horseradish peroxidase
  • Aa-4B S'ACCCATCTCTGAGTTCTTCTTCGGS' 990-1030
  • Example 9 Kit for Diagnosing Periodontal Disease by Measuring Total Bacterial Load
  • the following components would comprise a kit useful for diagnosing periodontal disease by estimating total bacterial load in tooth pockets.
  • the Product Insert will contain complete written instructions for patient sampling and evaluation.
  • a Data Card will be included for the recording of minimal baseline data for each patient, such as patient identification, site of collection, and test results. Curettes. Curettes for sampling by scraping.
  • Endodontic Points Endodontic points (paper points) for collection of each sample to be tested are also included. After cleansing the supragingival surfaces by wiping with gauze, the point will be used to rub the bacteria from the subgingival surface of the tooth to be sampled and to collect bacteria by absorption of saliva, gingival fluid, and gingival plaque.
  • Lysing Reagent Each point or curette with the collected sample will be placed immediately into a numbered tube of Lysing Reagent which will lyse the bacteria and release the bacterial nucleic acids.
  • Probe/Enzyme Reagent A standard aliquot of probe labeled by a ligand with or directly conjugated to an Enzyme Reagent is added to each tube of Lysing Reagent to initiate the hybridization reaction between the bacterial nucleic acid targets and the signal oligonucleotide probes derived from conserved regions of the ribosomal RNA sequences.
  • Dipstick Device An individual Dipstick Device containing site(s) with bacteria-specific DNA probes covalently immobilized to the solid support and having space for marking and identifying each site tooth sampled, is inserted immediately into each tube containing the hybridization mixture and incubated at room temperature.
  • Each Dipstick Device is removed from the hybridization mixture and washed with the Wash Reagent, using the container provided.
  • the Dipstick Devices are placed collectively into the Enzyme Substrate Reagent container and developed for several minutes to 1 hour at room tempera ⁇ ture. Each Dipstick Device is washed again with the Wash Reagent to remove excess background color. Reference Card. Color development is visualized and compared with a Reference Card, indicating the quantity of bacteria by comparisons with known standards.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Small-Scale Networks (AREA)
  • Communication Control (AREA)

Abstract

Cette invention concerne une méthode pour quantifier des bactéries au moyen d'une sonde bactérienne spécifique d'acide nucléique qui est complémentaire d'une région unique extrêmement protégée de l'ARN ribrosomique 16S (ARNr) des bactéries. Cette sonde permet la détection rapide de l'ARNr 16S dans un échantillon et par comparaison avec les normes connues , on peut estimer la numération bactérienne totale dans l'échantillon. La méthode est précise et reproductible et mise en oeuvre à des températures comprises entre environ 12 ° et environ 40 °C.
EP19900911234 1989-07-11 1990-07-10 Quantification of bacteria using a nucleic acid hybridization assay Withdrawn EP0484385A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37835589A 1989-07-11 1989-07-11
US378355 1989-07-11

Publications (2)

Publication Number Publication Date
EP0484385A1 true EP0484385A1 (fr) 1992-05-13
EP0484385A4 EP0484385A4 (en) 1993-05-26

Family

ID=23492807

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900911234 Withdrawn EP0484385A4 (en) 1989-07-11 1990-07-10 Quantification of bacteria using a nucleic acid hybridization assay

Country Status (4)

Country Link
EP (1) EP0484385A4 (fr)
JP (1) JPH05501052A (fr)
AU (1) AU6075490A (fr)
WO (1) WO1991000926A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060237A (en) * 1985-02-26 2000-05-09 Biostar, Inc. Devices and methods for optical detection of nucleic acid hybridization
EP0502271A1 (fr) * 1989-04-17 1992-09-09 The Standard Oil Company Sondes d'oligonucléotides de 16s rDNA pour l'identification de bactéries sulfato-réductrices
CA2150986C (fr) * 1994-06-17 1999-11-02 Mary Kathryn Meyer Amorces et sondes d'oligonucleotides pour la detection de bacteries
US5656427A (en) * 1994-08-29 1997-08-12 Gen-Probe Incorporated Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid
FR2733754B1 (fr) * 1995-05-05 1997-05-30 Univ Angers Fragment de l'adn genomique de clavibacter michiganensis, sonde d'hybridation, amorce d'amplification, reactif et procede de detection de clavibacter michiganensis
US5925518A (en) * 1995-05-19 1999-07-20 Akzo Nobel N.V. Nucleic acid primers for amplification of a mycobacteria RNA template
DE19709881A1 (de) * 1997-03-11 1998-09-17 Huels Chemische Werke Ag Verfahren zur Quantifizierung von Bakterien
FR2769323B1 (fr) * 1997-10-08 2001-07-13 Suez Lyonnaise Des Eaux Moyens pour l'analyse qualitative et quantitative des populations microbiennes eventuellement presentes dans un echantillon
US6511804B1 (en) * 1998-03-27 2003-01-28 Saigene Corporation Selective assay for determining the identity of live microorganisms in a mixed culture
US7465540B2 (en) 2000-09-21 2008-12-16 Luminex Corporation Multiple reporter read-out for bioassays
DE10215238C1 (de) * 2002-04-06 2003-08-14 Cytonet Gmbh & Co Kg Nachweis von Mykobakterien in klinischem Material

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127327A1 (fr) * 1983-04-29 1984-12-05 National Research Development Corporation Méthode de détermination de la séquence des nucléotides dans des cellules et d'isolation des acides nucléiques des cellules
WO1987006621A1 (fr) * 1986-05-02 1987-11-05 David Gillespie Procede chaotropique d'evaluation d'acides nucleiques dans un specimen biologique
WO1989006704A1 (fr) * 1988-01-11 1989-07-27 Microprobe Corporation Sondes d'oligonucleotides servant a la detection de pathogenes du periodonte

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI72146C (fi) * 1985-01-02 1987-04-13 Orion Yhtymae Oy Foerfarande foer identifiering av nukleinsyror.
AU616646B2 (en) * 1986-11-24 1991-11-07 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127327A1 (fr) * 1983-04-29 1984-12-05 National Research Development Corporation Méthode de détermination de la séquence des nucléotides dans des cellules et d'isolation des acides nucléiques des cellules
WO1987006621A1 (fr) * 1986-05-02 1987-11-05 David Gillespie Procede chaotropique d'evaluation d'acides nucleiques dans un specimen biologique
WO1989006704A1 (fr) * 1988-01-11 1989-07-27 Microprobe Corporation Sondes d'oligonucleotides servant a la detection de pathogenes du periodonte

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, USA vol. 82, October 1985, WASHINGTON, USA pages 6955 - 6959 LANE, D. ET AL. 'Rapid determination of +&S ribosomal RNA sequences for phylogenetic analyses' *
See also references of WO9100926A1 *

Also Published As

Publication number Publication date
JPH05501052A (ja) 1993-03-04
AU6075490A (en) 1991-02-06
WO1991000926A1 (fr) 1991-01-24
EP0484385A4 (en) 1993-05-26

Similar Documents

Publication Publication Date Title
US5212059A (en) Oligonucleotide probes for the detection of periodontal pathogens
JP2733700B2 (ja) 歯周囲病原体検出用オリゴヌクレオチドプローブ
US5334501A (en) Quantification of bacteria using a nucleic acid hybridization assay
US6015666A (en) Rapid DNA test for detecting quinolone-resistant Staphylococcus aureus pathogens in clinical material
US5770373A (en) Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probe specific for ribosomal RNA precursors
EP2256218B1 (fr) Amorces pour la détection du bacille tuberculeux et procédé de détection du bacille tuberculeux humain avec celles-ci
JP3436538B2 (ja) 改良型の鎖置換アッセイおよびそれに有用な複合体
KR19990067080A (ko) 특정 뉴클레오티드 서열의 검출방법 및 조성물
US7270982B2 (en) Helicobacter pylori antigens in blood
Sethabutr et al. Detection of PCR products of the ipaH gene from Shigella and enteroinvasive Escherichia coli by enzyme linked immunosorbent assay
WO2005083122A2 (fr) Methode de detection de micro-organisme dans un echantillon fecal
JPH0284200A (ja) カンピロバクターを検出するための核酸フラグメント、方法およびキット
EP0484385A1 (fr) Quantification de bacteries au moyen d'un dosage d'hybridation d'acide nucleique
US5314801A (en) Probes to Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium paratuberculosis
JPH05507206A (ja) レジオネラ種の検出用ｐｃｒプライマーおよびハイブリダイゼーションアッセイにおける光学的強度の調整方法
US6355435B1 (en) Methods for detecting and enumerating Campylobacter jejuni in environmental samples and for identifying antibiotic-resistant strains
US5389515A (en) Isolated nucleotide sequences for identifying Neisseria gonorrhoeae
US5173401A (en) Detection of neisseria gonorrohoeae
JPH06209797A (ja) カンジダ・アルビカンス（Ｃａｎｄｉｄａ ａｌｂｉｃａｎｓ）の診断的研究のための特異的遺伝子のプローブ
JPH09502100A (ja) ｃａｍｐｙｌｏｂａｃｔｅｒの検出および種形成
US5432055A (en) Detection of Porphyromonas gingivalis
JP2004525626A (ja) ｉｎｓｉｔｕハイブリダイゼーションにより歯周病原性細菌を検出するためのオリゴヌクレオチド・プローブ
JPH10508499A (ja) カンピロバクターのゲノム核酸配列と特異的にハイブリダイズするヌクレオチド配列
AU627712B2 (en) Oligonucleotide probes for detection of periodontal pathogens
JP2004514437A (ja) ネグレリア属の原虫を検出する方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930402

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19950727

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BECTON DICKINSON AND COMPANY

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 12Q 1/68 A

RIC1 Information provided on ipc code assigned before grant

Free format text: 6C 12Q 1/68 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010131